RCUSArcus Biosciences, Inc.

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key: 20827
Ticker: RCUS
Type: CS — Common Stock
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2018-03-15
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: RCUS

Detail

Enriched 2026-08-14 20:47

Market cap: $3,687,574,568.96
Shares outstanding (class): 127,333,376
Shares outstanding (weighted): 127,333,376
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 601
Location: HAYWARD, CA
Homepage: https://www.arcusbio.com
Description: Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Market cap and share counts drift.

Funds holding this security

124 funds · 131 positions · $481.06M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Small-Cap ETF iShares Trust	IJR	$109.90M	0.12%	5,087,817 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$60.85M	0.00%	2,817,036 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$46.73M	0.63%	2,163,363 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$44.23M	0.06%	2,047,732 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$21.90M	0.01%	1,013,765 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$20.45M	0.03%	946,591 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 600(TM) S… SPDR SERIES TRUST	SPSM	$16.54M	0.12%	765,755 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$13.23M	0.16%	612,355 NS	FIGI
VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS	VBK	$12.27M	0.03%	567,890 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$10.89M	0.09%	504,219 NS	FIGI
VANGUARD TAX-MANAGED SMALL-CAP FUND VANGUARD TAX-MANAGED FUNDS	—	$10.44M	0.11%	483,501 NS	FIGI
iShares S&P Small-Cap 600 Growth ETF iShares Trust	IJT	$9.95M	0.15%	460,769 NS	FIGI
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$8.19M	1.23%	379,100 NS	FIGI
iShares S&P Small-Cap 600 Value ETF iShares Trust	IJS	$6.60M	0.09%	305,570 NS	FIGI
abrdn Healthcare Investors —	—	$6.49M	0.57%	300,310 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERRCUS
FIGI_COMPOSITEBBG00DQD26W3
FIGI_SHARE_CLASSBBG00DQD2751
CIK0001724521
ISINUS03969F1093
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: SIC code 2834 indicates pharmaceutical preparations, and the company is a biopharmaceutical firm.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.